Search results

Source:

Clinical Knowledge Summaries - CKS (Remove filter)

01 February 2021

Always prescribe lithium by brand name as preparations vary widely in bioavailability.

Type:

Guidance (Remove filter)

Source:

Department of Health (Add filter)

Source:

GOV UK (Remove filter)

22 December 2020

Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.

Type:

Policy and Strategy (Remove filter)

Source:

British Association for Psychopharmacology - BAP (Remove filter)

Published by British Association for Psychopharmacology, 11 December 2019

These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for...

Read Summary

Type:

Guidance (Remove filter)

Source:

British Association for Psychopharmacology - BAP (Remove filter)

Published by British Association for Psychopharmacology, 28 May 2012

These guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based...

Read Summary

Type:

Guidance (Remove filter)

Source:

EUnetHTA (Remove filter)

Published by EUnetHTA, 24 April 2017

The purpose of the assessment is to examine the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in adult patients with treatment-resistant major depression. The...

Read Summary

Type:

Health Technology Assessments (Remove filter)